US adults believing they were given a more expensive version of a drug by gender 2017

Percentage of U.S. adults that believe they were prescribed a more expensive version of drug as of 2017, by gender

by Alexander Kunst, last edited Sep 3, 2019
US adults believing they were given a more expensive version of a drug by gender 2017 This statistic shows the results of a survey conducted in the United States in February 2017, by gender. U.S. adults were asked if they believe they were prescribed a more expensive version of a drug even though a cheaper one was available that had the same effect. In total, 6 percent of female respondents and 9 percent of male respondents believe they were always given a more expensive version of a drug.
Show more

Percentage of U.S. adults that believe they were prescribed a more expensive version of drug as of 2017, by gender

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Health care and cyber security"
  • Overview
The most important statistics
  • Health care vs. other sectors
  • Attacks/data breaches
  • Consequences/measures
  • The consumer's view
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.